Other NAP books related by word and phrase frequencies

The following titles are likely to be of interest to you. The top keyword and keyphrase weights from this report have been compared with the equivalent lists of words and phrases for all other available NAP publications.

• Safe Medical Devices for Children (ISBN ) Marilyn J. Field and Hugh Tilson, Editors, Committee on Postmarket Surveillance of Pediatric Medical Devices


• Rare Diseases and Orphan Products: Accelerating Research and Development (ISBN ) Marilyn J. Field and Thomas F. Boat, Editors; Committee on Accelerating Rare Diseases Research and Orphan Product Development; Institute of Medicine


• Addressing the Barriers to Pediatric Drug Development: Workshop Summary (ISBN ) Cori Vanchieri, Adrienne Stith Butler, and Andrea Knutsen, Rapporteurs; Forum on Drug Discovery, Development, and Translation; Institute of Medicine


• The Future of Drug Safety: Promoting and Protecting the Health of the Public (ISBN ) Committee on the Assessment of the US Drug Safety System, Alina Baciu, Kathleen Stratton, Sheila P. Burke, Editors


• Rational Therapeutics for Infants and Children:Workshop Summary (ISBN ) Sumner Yaffe, M.D., Editor; Ronald W. Estabrook, Peter Bouxsein, Sarah Pitluck, Jonathan R. Davis, Roundtable on Research and Development of Drugs, Biologics, and Medical Devices, Division of Health Sciences Policy


• The Ethical Conduct of Clinical Research Involving Children (ISBN ) Marilyn J. Field and Richard E. Berman, Editors, Committee on Clinical Research Involving Children


• Ethical and Scientific Issues in Studying the Safety of Approved Drugs (ISBN ) Committee on Ethical and Scientific Issues in Studying the Safety of Approved Drugs; Institute of Medicine


• Emergency Care for Children: Growing Pains (ISBN ) Committee on the Future of Emergency Care in the United States Health System


• Preventing Medication Errors: Quality Chasm Series (ISBN ) Committee on Identifying and Preventing Medication Errors, Philip Aspden, Julie Wolcott, J. Lyle Bootman, Linda R. Cronenwett, Editors


• New Treatments for Addiction: Behavioral, Ethical, Legal, and Social Questions (ISBN ) Henrick J. Harwood and Tracy G. Myers, Editors, Committee on Immunotherapies and Sustained-Release Formulations for Treating Drug Addiction, National Research Council


• Challenges for the FDA: The Future of Drug Safety, Workshop Summary (ISBN ) Leslie Pray and Sally Robinson, Rapporteurs, Forum on Drug Discovery, Development, and Translation


• Animal Models for Assessing Countermeasures to Bioterrorism Agents (ISBN ) Committee on Animal Models for Assessing Countermeasures to Bioterrorism Agents; National Research Council


• Food and Drug Administration Advisory Committees (ISBN ) Richard A. Rettig, Laurence E. Earley, and Richard A. Merrill, Editors; Committee to Study the Use of Advisory Committees, Institute of Medicine


• When Children Die:Improving Palliative and End-of-Life Care for Children and Their Families (ISBN ) Marilyn J. Field and Richard E. Behrman, Editors, Committee on Palliative and End-of-Life Care for Children and Their Families


• The Safe Use Initiative and Health Literacy: Workshop Summary (ISBN ) Cori Vancheri, Rapporteur; Roundtable on Health Literacy; Institute of Medicine


• Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease (ISBN ) Christine M. Micheel and John R. Ball, Editors; Committee on Qualifications of Biomarkers and Surrogate Endpoints in Chronic Disease; Institute of Medicine


• Assuring Data Quality and Validity in Clinical Trials for Regulatory Decision Making:Workshop Report (ISBN ) Jonathan R. Davis, Vivian P. Nolan, Janet Woodcock, and Ronald W. Estabrook, Editors; Roundtable on Research and Development of Drugs, Biologics, and Medical Devices, Institute of Medicine


• Medical Devices and the Public's Health: The FDA 510(k) Clearance Process at 35 Years (ISBN ) Committee on the Public Health Effectiveness of the FDA 510(k) Clearance Process; Institute of Medicine


• Federal Agency Roles in Cancer Drug Development from Preclinical Research to New Drug Approval: The National Cancer Institute and the Food and Drug Administration (ISBN )


• An Assessment of the CDC Anthrax Vaccine Safety and Efficacy Research Program (ISBN ) Committee to Review the CDC Anthrax Vaccine Safety and Efficacy Research Program


• Making Better Drugs for Children with Cancer (ISBN ) Peter C. Adamson, Susan L Weiner, Joseph V. Simone, and Hellen Gelband, Editors, Committee on Shortening the Time Line for New Cancer Treatments, Institute of Medicine and the National Research Council


• Dietary Reference Intakes: Guiding Principles for Nutrition Labeling and Fortification (ISBN ) Committee on Use of Dietary Reference Intakes in Nutrition Labeling


• Scientific Standards for Studies on Modified Risk Tobacco Products (ISBN ) Committee on Scientific Standards for Studies on Modified Risk Tobacco Products; Institute of Medicine


• Biological Threats and Terrorism: Assessing the Science and Response Capabilities: Workshop Summary (ISBN ) Stacey L. Knobler, Adel A.F. Mahmoud, and Leslie A. Pray, Editors, Forum on Emerging Infections, Board on Global Health


• The Social Impact of AIDS in the United States (ISBN ) Panel on Monitoring the Social Impact of the AIDS Epidemic, National Research Council


• Informing the Future: Critical Issues in Health, Fourth Edition (ISBN )


• The Development of Medications for the Treatment of Opiate and Cocaine Addictions:Issues for the Government and Private Sector (ISBN ) Carolyn E. Fulco, Catharyn T. Liverman, and Laurence E. Earley, Editors; Committee to Study Medication Development and Research at the National Institute on Drug Abuse, Institute of Medicine


• Leadership Commitments to Improve Value in Health Care:Finding Common Ground: Workshop Summary (ISBN ) LeighAnne Olsen, W. Alexander Goolsby, and J. Michael McGinnis; Roundtable on Evidence-Based Medicine


• Halcion:An Independent Assessment of Safety and Efficacy Data (ISBN ) Committee on Halcion: An Assessment of Data Adequacy and Confidence, Division of Health Sciences Policy, Institute of Medicine


• A Risk-Characterization Framework for Decision-Making at the Food and Drug Administration (ISBN ) Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II; National Research Council


• Review of the HIVNET 012 Perinatal HIV Prevention Study (ISBN ) Committee on Reviewing the HIVNET 012 Perinatal HIV Prevention Study, Board on Population Health and Public Health Practice


• Ethical Issues in Studying the Safety of Approved Drugs:A Letter Report (ISBN ) Committee on Ethical and Scientific Issues in Studying the Safety of Approved Drugs; Institute of Medicine


• Complementary and Alternative Medicine in the United States (ISBN ) Committee on the Use of Complementary and Alternative Medicine by the American Public


• Expanding Access to Investigational Therapies for HIV Infection and AIDS (ISBN ) Roundtable for the Development of Drugs and Vaccines Against AIDS, Institute of Medicine


• The Changing Economics of Medical Technology (ISBN ) Annetine C. Gelijns and Ethan A. Halm, Editors; Committee on Technological Innovation in Medicine, Institute of Medicine


• The Childhood Immunization Schedule and Safety: Stakeholder Concerns, Scientific Evidence, and Future Studies (ISBN ) Committee on the Assessment of Studies of Health Outcomes Related to the Recommended Childhood Immunization Schedule; Board on Population Health and Public Health Practice; Institute of Medicine


• Improving Palliative Care for Cancer (ISBN ) Kathleen M. Foley and Hellen Gelband, Editors, National Cancer Policy Board, National Research Council


• Proposed Framework for Evaluating the Safety of Dietary Supplements -- For Comment (ISBN )


• Advancing Regulatory Science for Medical Countermeasure Development: Workshop Summary (ISBN ) Theresa Wizemann, Bruce M. Altevogt, and Anne B. Claiborne, Rapporteurs; Forum on Drug Discovery, Development, and Translation; Forum on Medical and Public Health Preparedness for Catastrophic Events; Institute of Medicine